FBRX 股價走勢圖
FBRX 股票價格預測
Forte Biosciences Inc
$76.5
39.64%
$21.72
收盤價：Jul 27, 16:00:00 GMT-4
$76.51
0.01%
$0.01
盤前：Jul 28, 09:41:48 GMT-4
返回
Forte Biosciences Inc (FBRX) 股票價格預測
關鍵數據
前收市價
$54.78
開盤價
$76.41
當日範圍
$76.39 - $76.58
52週區間
$9.1 - $76.51
交易量
17.1M
平均成交量
315.2K
股息收益率
--
每股盈餘 (TTM)
-4.58
市值
$1.5B
什麼是 FBRX？
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The company is headquartered in Dallas, Texas and currently employs 19 full-time employees. The company went IPO on 2017-04-13. The company is advancing clinical development of FB102 into patient-based trials for celiac disease and non-segmental vitiligo. The firm's FB102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and certain T cell subsets. FB102 has potentially other autoimmune and autoimmune-related applications including vitiligo, alopecia areata, and type 1 diabetes (T1D). Its subsidiaries include Forte Subsidiary, Inc. and Forte Biosciences Australia Proprietary Limited.
